Released: March 5, 2014

Defense Health Program
Department of Defense Bone Marrow Failure Research Program
Funding Opportunities for Fiscal Year 2014 (FY14)

The FY14 Defense Appropriations Act provides $3.2 million (M) to the Department of Defense Bone Marrow Failure Research Program (BMFRP) to support innovative research committed to advancing the understanding of inherited and acquired bone marrow failure diseases. This program is administered by the US Army Medical Research and Materiel Command (USAMRMC) through the Office of Congressionally Directed Medical Research Programs (CDMRP).

The BMFRP is providing the information in this pre-announcement to allow investigators time to plan and develop applications. FY14 BMFRP Program Announcement and General Application Instructions for the following award mechanism are anticipated to be posted on the website in March 2014. Pre-application and application deadlines will be available when the Program Announcement is released. This pre-announcement should not be construed as an obligation by the government. Funding is contingent on receipt of appropriations.

Award Mechanism Eligibility Key Mechanism Elements Funding
Idea Development Award Investigators at or above the level of Assistant Professor (or equivalent)
  • Supports innovative ideas and high-impact approaches based on scientifically sound evidence in order to move towards the vision to understand and cure BMF
  • Strong BMF research team
  • May include relevant preliminary data
  • Clinical trials will not be supported
  • Maximum funding of $400,000 in direct costs (plus indirect costs)
  • Period of performance not to exceed 3 years

All applications must conform to the final Program Announcement and General Application Instructions that will be available for electronic downloading from the website. The application package containing the required forms for the award mechanism will also be found on A listing of all USAMRMC funding opportunities can be obtained on the website by performing a basic search using CFDA Number 12.420.

Pre-applications are required and must be submitted through the CDMRP electronic Biomedical Research Application Portal (eBRAP) ( Applications must be submitted through the federal government's single-entry portal, Submission deadlines are not available until the Program Announcement is released. Requests for email notification of the Program Announcement release may be sent to Email notifications of funding opportunities are sent as a courtesy and should not be used as a sole source of notification; applicants should monitor for official postings of funding opportunities.

For more information about the BMFRP or other CDMRP-administered programs, please visit the CDMRP website (

Point of Contact: